Search Within

Eric J Sherman

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (22)
  2. Meeting Abstract (15)
  3. Guidelines (1)
Groups
  1. Department of Medicine (38)
  2. GSK Faculty (38)
  3. Head and Neck Service (38)
  4. Human Oncology and Pathogenesis Program (38)
  5. Solid Tumor Oncology Division (38)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (36)

More Groups

People
  1. James Fagin (35)
  2. Ronald Ghossein (21)
  3. Alan Ho (20)
  4. Robert Tuttle (19)
  5. David Pfister (15)
  6. Mona Sabra (11)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (9)
  5. 2021 (2)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Thyroid (5)
  3. International Journal of Radiation Oncology, Biology, Physics (3)
  4. Annals of Oncology (2)
  5. Cancer (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. American Association for Cancer Research (5)
  3. Mary Ann Liebert, Inc (5)
  4. Wiley Blackwell (4)
  5. Elsevier Inc. (3)
  6. Nature Publishing Group (3)

More Publishers

Results (38)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity
    Journal Article

    Dong, Y.; Gong, Y.; Kuo, F.; Makarov, V.; Reznik, E.; Nanjangud, G. J.; Aras, O.; Zhao, H.; Qu, R.; Fagin, J. A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Primary high-grade non-anaplastic thyroid carcinoma: A retrospective study of 364 cases
    Journal Article

    Xu, B.; David, J.; Dogan, S.; Landa, I.; Katabi, N.; Saliba, M.; Khimraj, A.; Sherman, E. J.; Tuttle, R. M.; Tallini, G.; more...
    Histopathology (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic correlates of thyroid carcinoma evolution after BRAF inhibitor therapy
    Journal Article

    Lee, M.; Untch, B. R.; Xu, B.; Ghossein, R.; Han, C.; Kuo, F.; Valero, C.; Nadeem, Z.; Patel, N.; Makarov, V.; more...
    Molecular Cancer Research (2022)

    Fulltext@MSK | Save
  • Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial
    Journal Article

    Romesser, P. B.; Sherman, E. J.; Whiting, K.; Ho, M. L.; Shaha, A. R.; Sabra, M. M.; Riaz, N.; Waldenberg, T. E.; Sabol, C. R.; Ganly, I.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • Co-inhibition of SMAD and MAPK signaling enhances (124)I uptake in BRAF-mutant thyroid cancers
    Journal Article

    Luckett, K. A.; Cracchiolo, J. R.; Krishnamoorthy, G. P.; Leandro-Garcia, L. J.; Nagarajah, J.; Saqcena, M.; Lester, R.; Im, S. Y.; Zhao, Z.; Lowe, S. W.; more...
    Endocrine-Related Cancer (2021)

    Fulltext@MSK | Save
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Dissecting anaplastic thyroid carcinoma: A comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases
    Journal Article

    Xu, B.; Fuchs, T.; Dogan, S.; Landa, I.; Katabi, N.; Fagin, J. A.; Tuttle, R. M.; Sherman, E.; Gill, A. J.; Ghossein, R.
    Thyroid (2020)

    Fulltext@MSK | Save
  • Dissecting anaplastic thyroid carcinoma (ATC): A comprehensive clinicohistologic, immunophenotypic, and molecular studies of 357 cases
    Meeting Abstract

    Xu, B.; Fuchs, T.; Dogan, S.; Landa, I.; Katabi, N.; Fagin, J.; Sherman, E.; Gill, A.; Ghossein, R.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers
    Journal Article

    Dunn, L. A.; Sherman, E. J.; Baxi, S. S.; Tchekmedyian, V.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save
  • Combination of dabrafenib (DAB) and lapatinib (LAP) for the treatment of BRAF-mutant thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fagin, J. A.; Haque, S.; Robinson, C.; Ghossein, R. A.; Chen, H. X.; Pfister, D. G.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save